The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...
Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention "We're proud to introduce the reimagined Kendall SCD device to our ...
KING OF PRUSSIA, Pa., Nov. 2, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that its investigational, plasma-derived hemopexin therapy (CSL889) received orphan drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback